Renal cell carcinoma echocardiography or ultrasound: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(6 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{CMG}} {{AE}} {{F.K}}
 
{{CMG}} {{AE}} {{Rim}} {{F.K}}
{{Renal cell carcinoma}}
{{Renal cell carcinoma}}


==Overview==
==Overview==
Ultrasound may be helpful in the diagnosis of renal cell carcinoma. Ultrasound (US) may be helpful when CT scan results are equivocal.  
[[Ultrasound]] may be helpful in the diagnosis of renal cell carcinoma. [[Ultrasound]] may be helpful when CT scan results are equivocal.  


==Ultrasound==
==Ultrasound==
Ultrasound may be helpful in the diagnosis of renal cell carcinoma. Ultrasound (US) may be helpful when CT scan results are equivocal.  
[[Ultrasound]] may be helpful in the diagnosis of renal cell carcinoma when CT scan results are equivocal.<ref name="pmid16339096">{{cite journal |vauthors=Cohen HT, McGovern FJ |title=Renal-cell carcinoma |journal=N. Engl. J. Med. |volume=353 |issue=23 |pages=2477–90 |date=December 2005 |pmid=16339096 |doi=10.1056/NEJMra043172 |url=}}</ref>
{|border="1" style="border-collapse:collapse; text-align:left;" cellpadding="5" align="center"
 
{| style="border-collapse:collapse; text-align:left;" cellpadding="5" border="1" align="center"
|+ '''''Use of US in Renal Cell Carcinoma<ref name="pmid23665399">{{cite journal| author=Donat SM, Diaz M, Bishoff JT, Coleman JA, Dahm P, Derweesh IH et al.| title=Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline. | journal=J Urol | year= 2013 | volume= 190 | issue= 2 | pages= 407-16 | pmid=23665399 | doi=10.1016/j.juro.2013.04.121 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23665399  }} </ref>'''''
|+ '''''Use of US in Renal Cell Carcinoma<ref name="pmid23665399">{{cite journal| author=Donat SM, Diaz M, Bishoff JT, Coleman JA, Dahm P, Derweesh IH et al.| title=Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline. | journal=J Urol | year= 2013 | volume= 190 | issue= 2 | pages= 407-16 | pmid=23665399 | doi=10.1016/j.juro.2013.04.121 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23665399  }} </ref>'''''
| bgcolor="#d9ff54"|'''Patient Profile''' || bgcolor="#d9ff54"|'''Use of US'''|| bgcolor="#d9ff54"|'''Evidence Strength'''
| style="background:#4479BA; color: #FFFFFF;" align="center" + |'''Patient Profile''' || style="background:#4479BA; color: #FFFFFF;" align="center" + |'''Use of US'''|| style="background:#4479BA; color: #FFFFFF;" align="center" + |'''Evidence Strength'''
|-
|-
| bgcolor="#ececec"|'''Low Risk Patient (pT1, N0, Nx)''' ||US (or CT or MRI) may be performed in patients following radical nephrectomy if initial post-op baseline image is negative||C
| bgcolor="#DCDCDC" |'''Low Risk Patient (pT1, N0, Nx)''' ||US (or CT or MRI) may be performed in patients following radical nephrectomy if initial post-op baseline image is negative||C
|-
|-
| bgcolor="#ececec"|'''Moderate to High Risk Patients (pT2-4N0 Nx or any stage N+)''' ||Imaging, including US, may be used every 6 months (after a baseline chest and abdominal CT or MRI within 3-6 months following surgery) for at least 3 years and annually thereafter to 5 years. Site specific imaging is warranted by clinical symptoms suggestive of recurrence or metastatic spread. Imaging (US, CXR, CT, or MRI) beyond 5 years may be performed at the discretion of the clinician|| C
| bgcolor="#DCDCDC" |'''Moderate to High Risk Patients (pT2-4N0 Nx or any stage N+)''' ||Imaging, including US, may be used every 6 months (after a baseline chest and abdominal CT or MRI within 3-6 months following surgery) for at least 3 years and annually thereafter to 5 years. Site specific imaging is warranted by clinical symptoms suggestive of recurrence or metastatic spread. Imaging (US, CXR, CT, or MRI) beyond 5 years may be performed at the discretion of the clinician|| C
|}
|}



Latest revision as of 16:48, 11 December 2018


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2] Farima Kahe M.D. [3]

Renal cell carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Renal cell carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural history, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Renal cell carcinoma echocardiography or ultrasound On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Renal cell carcinoma echocardiography or ultrasound

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Renal cell carcinoma echocardiography or ultrasound

CDC on Renal cell carcinoma echocardiography or ultrasound

Renal cell carcinoma echocardiography or ultrasound in the news

Blogs on Renal cell carcinoma echocardiography or ultrasound

Directions to Hospitals Treating Renal cell carcinoma

Risk calculators and risk factors for Renal cell carcinoma echocardiography or ultrasound

Overview

Ultrasound may be helpful in the diagnosis of renal cell carcinoma. Ultrasound may be helpful when CT scan results are equivocal.

Ultrasound

Ultrasound may be helpful in the diagnosis of renal cell carcinoma when CT scan results are equivocal.[1]

Use of US in Renal Cell Carcinoma[2]
Patient Profile Use of US Evidence Strength
Low Risk Patient (pT1, N0, Nx) US (or CT or MRI) may be performed in patients following radical nephrectomy if initial post-op baseline image is negative C
Moderate to High Risk Patients (pT2-4N0 Nx or any stage N+) Imaging, including US, may be used every 6 months (after a baseline chest and abdominal CT or MRI within 3-6 months following surgery) for at least 3 years and annually thereafter to 5 years. Site specific imaging is warranted by clinical symptoms suggestive of recurrence or metastatic spread. Imaging (US, CXR, CT, or MRI) beyond 5 years may be performed at the discretion of the clinician C

References

  1. Cohen HT, McGovern FJ (December 2005). "Renal-cell carcinoma". N. Engl. J. Med. 353 (23): 2477–90. doi:10.1056/NEJMra043172. PMID 16339096.
  2. Donat SM, Diaz M, Bishoff JT, Coleman JA, Dahm P, Derweesh IH; et al. (2013). "Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline". J Urol. 190 (2): 407–16. doi:10.1016/j.juro.2013.04.121. PMID 23665399.